REXAHN PHARMACEUTICALS, INC. 4

4 · REXAHN PHARMACEUTICALS, INC. · Filed Sep 11, 2013

Form 4

Period: 2013-09-09

DirectorCFO

Transactions

Tax Payment
Common Stock
2013-09-09$0.46/sh−78,861$36,000→ 576,139 total
Sale
Common Stock
2013-09-09$0.46/sh−71,139$32,475→ 505,000 total
Exercise/Conversion
Common Stock
2013-09-09$0.24/sh+150,000$36,000→ 655,000 total
Exercise/Conversion
Stock Option (right to purchase)
2013-09-09−150,000→ 0 total
Exercise: $0.24Exp: 2013-10-04→ Common Stock (150,000 underlying)

Holdings

Stock Option (right to purchase)
Exercise: $0.31Exp: 2023-03-01→ Common Stock (250,000 underlying)
250,000
Stock Option (right to purchase)
Exercise: $0.80Exp: 2015-01-20→ Common Stock (500,000 underlying)
500,000
Stock Option (right to purchase)
Exercise: $0.78Exp: 2018-12-11→ Common Stock (250,000 underlying)
250,000
Stock Option (right to purchase)
Exercise: $0.80From: 2005-12-01Exp: 2013-10-04→ Common Stock (100,000 underlying)
100,000

Footnotes (6)

[F1]Reflects shares withheld by the issuer at the weighted average sales price of 0.4565 per share to fund the cashless exercise of 150,000 options.
[F2]Options will vest and be exercisable based on the following schedule: 75,000 on March 1, 2014, 75,000 on March 1, 2015, and 100,000 on March 1, 2016.
[F3]Options vested and became exercisable based on the following schedule 75,000 on December 11, 2009, 75,000 on December 11, 2010, and 100,000 on December 11, 2011.
[F4]Options vested and became exercisable based on the following schedule 150,000 on January 20, 2006, 150,000 on January 20, 2007, and 200,000 on January 20, 2008.
[F5]Options were due to expire on August 5, 2003, however, the Compensation Committee of the Board of Directors of Rexahn Pharmaceuticals, Inc. (the "Company") extended the expiration date because the Company was in a blackout period at that time. The expiration date was extended to 30 days from the end of the blackout period, which is October 4, 2013.
[F6]Options vested and became exercisable based on the following schedule 75,000 on December 1, 2003 and 75,000 on December 1, 2004.

Documents

1 file